4.3 Article

Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 301, Issue -, Pages 7-11

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2016.10.015

Keywords

Multiple sclerosis (MS); Experimental autoimmune encephalomyelitis (EAE); Remyelination; In vivo metabolic labeling; Quantitative colocalization analysis; Glatiramer acetate (GA)

Funding

  1. Teva Pharmaceuticals [1575]

Ask authors/readers for more resources

The lack of biomarkers is a major obstacle for investigating myelin repair. We used metabolic incorporation of the choline analog - propargyl-choline (P-Cho) to label and visualize newly synthesized myelin in the CNS of mice induced with experimental autoimmune encephalomyelitis (EAE). We further developed unbiased colocalization analysis to quantify P-Cho incorporation specifically into the myelin. Our findings indicate that P-Cho injection to mice recovering from EAE, either spontaneously or following glatiramer acetate treatment, results in significant elevation of its incorporation into the myelin, offering a novel strategy for assessing remyelination in animal models and the remyelination potential of candidate drugs. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available